Skip to main content
Move the World.
FDA Approves the First Marijuana-based Drug

For the first time, the FDA has approved a medicine derived from marijuana for use in the United States. The drug is a purified solution of 100% cannabidiol (or CBD), a naturally occurring compound found in marijuana plants, and it will be used to treat patients with rare, devastating forms of childhood epilepsy.

CBD is not psychoactive, but the DEA still classifies it as a Schedule I controlled substance, just like marijuana, insisting that it has “no accepted medical use” and “a high potential for abuse.” Although the FDA has concluded that CBD does have a medical use (and a “negligible abuse potential”), it’s up to the DEA to reclassify it before it can be sold in pharmacies.

Laws, Seizures, and CBD: Although scientists had thought that CBD might protect against seizures since at least 2004, marijuana laws made researching the plant difficult. But in 2012 and 2013, stories began emerging about kids with Dravet's syndrome (a severe form of childhood epilepsy) dramatically reducing their seizures with CBD. Dozens of states responded by legalizing CBD or expanding their medical access laws to cover epilepsy.

Legal status of CBD in the U.S. under
state law.

Legal status of CBD in the U.S. under
state law. Credit: Gleb Oleinik

Legalization at the state level and greater attention from the public made researching CBD an easier lift, and a number of high-quality studies were launched to see if it could treat epilepsy that wouldn’t respond to other drugs. Ultimately, three gold-standard clinical trials convinced the FDA that CBD does indeed help with intractable seizures. This year marks the first time that a drug made from the marijuana plant itself has been approved as a safe and effective medical treatment.

The DEA Isn't Feeling It: Unfortunately for epilepsy patients, the FDA can approve CBD for medical uses, but the DEA still has the final say over whether it’s legal. If the agency doesn’t move it off the Schedule I list of banned substances, it won’t be hitting pharmacy shelves any time soon. Industry experts and the drug manufacturer who pushed CBD through the FDA approvals process seem confident that the DEA will downgrade it within 90 days.

But, as recently as May, the DEA was fighting tooth and nail in federal court to keep CBD on the Schedule I list. Even stranger, technically CBD has never been a controlled substance—unlike the psychoactive THC compound, which has its own listing, the cannabidiol compound is not mentioned on any list of restricted drugs. Instead, in just 2016, the DEA banned CBD through the backdoor, by declaring it and anything else made from marijuana to be “marijuana extract,” and therefore inherently just as illegal.

How this muddle of science and regulations will play out is anyone's guess, but now the ball is entirely in the DEA's court.

Up Next

Memory
Reminiscence Therapy Is Helping Seniors at “Dementia Villages”
Reminiscence Therapy
Memory
Reminiscence Therapy Is Helping Seniors at “Dementia Villages”
At a growing number of “dementia villages,” staff members use reminiscence therapy to help seniors return to a time when they felt happy and safe.

At a growing number of “dementia villages,” staff members use reminiscence therapy to help seniors return to a time when they felt happy and safe.

Dope Science
Legal Pot Is Finally Growing Up and Going to College
cannabis degree program
Dope Science
Legal Pot Is Finally Growing Up and Going to College
As medical marijuana becomes mainstream, so does the need for an educated workforce in the industry. Enter the nation's first-ever cannabis degree program.

As medical marijuana becomes mainstream, so does the need for an educated workforce in the industry. Enter the nation's first-ever cannabis degree program.

Year in Review
Freethink's Favorite Behind the Scenes Insights from 2019
Freethink's Favorite Behind the Scenes Insights from 2019
Year in Review
Freethink's Favorite Behind the Scenes Insights from 2019
Join Freethink's directors behind the scenes to discover the experiences and insights that went into creating some of our favorite videos from 2019.

Join Freethink's directors behind the scenes to discover the experiences and insights that went into creating some of our favorite videos from 2019.

Birdwatch
The Dark Toll of Light Pollution
The Dark Toll of Light Pollution
Birdwatch
The Dark Toll of Light Pollution
Bird populations are paying the price for our electric lights. These volunteers are working to change that.

Bird populations are paying the price for our electric lights. These volunteers are working to change that.

Thinking Differently
How Science Is Learning to Admit Mistakes
How Science Is Learning to Admit Mistakes
Thinking Differently
How Science Is Learning to Admit Mistakes
A shocking amount of scientific studies can’t be reproduced. Do we need to change the culture of science?

A shocking amount of scientific studies can’t be reproduced. Do we need to change the culture of science?

Thinking Differently
The Joy of Being Wrong
The Joy of Being Wrong
Watch Now
Thinking Differently
The Joy of Being Wrong
Can practicing intellectual humility make us smarter and happier? Science says yes.
Watch Now

Arguments on social media are notorious. People often naturally form an echo chamber of people with similar beliefs, and when people outside it start arguments, the discussion often becomes antagonistic. Is there a better way? Science suggests that a good starting point is by practicing intellectual humility. By admitting the possibility that we ourselves could be wrong, we’re able to better evaluate arguments and construct...

#fixingjustice - Prosecution
Exclusive Interview: How Miriam Krinsky is Leading Us to a Smarter & More...
Miriam Krinsky
#fixingjustice - Prosecution
Exclusive Interview: How Miriam Krinsky is Leading Us to a Smarter & More...
Her organization is bringing together a new generation of prosecutors with a shared vision of fair, compassionate,...

Her organization is bringing together a new generation of prosecutors with a shared vision of fair, compassionate, and responsible criminal justice reform.

Steven Pinker Makes the Case for Optimism
Steven Pinker Makes the Case for Optimism
Watch Now
Steven Pinker Makes the Case for Optimism
Are things really worse than ever, or are we missing the bigger picture?
Watch Now

Author and Harvard professor Steven Pinker lays out what he see as a basic paradox. The news today seems worse than ever - but based on a number of key metrics, Pinker argues the world is better than it’s ever been. Pinker explores the data and makes the case for how can we tackle the world’s problems while not drowning in negativity. That’s the focus of his latest book, Enlightenment Now: The Case for Reason, Science,...